Sun Yat-sen University: Small Cell Lung Carcinoma trials

The registry lists 12 Small Cell Lung Carcinoma studies with Sun Yat-sen University as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 12Phase 3 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• QL1706 Plus Anlotinib as a Later-line Treatment for Patients With Advanced Lung CancerNot yet recruitingNCT07636226Phase 2/3
• Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled StudyRecruitingNCT07583511Phase 2
• A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung CancerNot yet recruitingNCT07103408Phase 2
• Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung CancerRecruitingNCT06719700Phase 2
• Toripalimab Plus Etoposide and Platinum-based Chemotherapy for Genitourinary Small Cell CarcinomaRecruitingNCT05760053Phase 2
• Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRTRecruitingNCT05623267Phase 2/3
• Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung CancerStatus unknownNCT04996771Phase 1/2
• Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed ChemotherapyStatus unknownNCT03811379Phase 2
• Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung CancerTerminatedNCT03661567Phase 2
• Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung CancerCompletedNCT03659578Phase 2
• Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung CancerCompletedNCT02573506Phase 2
• Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung CancerStatus unknownNCT02337712Phase 2